According to Tandem Diabetes Care 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.15686. At the end of 2023 the company had a P/S ratio of 2.58.
Year | P/S ratio | Change |
---|---|---|
2023 | 2.58 | -28.49% |
2022 | 3.61 | -73.49% |
2021 | 13.6 | 14.06% |
2020 | 11.9 | 22.07% |
2019 | 9.77 | -17.78% |
2018 | 11.9 | 5255.5% |
2017 | 0.2219 | -71.62% |
2016 | 0.7820 | -84.06% |
2015 | 4.90 | -18.82% |
2014 | 6.04 | -70.34% |
2013 | 20.4 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 3.88 | 22.87% | ๐บ๐ธ USA |
Medtronic MDT | 3.32 | 5.31% | ๐ฎ๐ช Ireland |
ICU Medical
ICUI | 1.07 | -66.16% | ๐บ๐ธ USA |
DexCom DXCM | 13.2 | 319.66% | ๐บ๐ธ USA |
Insulet PODD | 7.16 | 126.66% | ๐บ๐ธ USA |